Investor Relations

Press, quotes, SEC filings, alerts, more.

COVID-19

OT-101 for COVID-19

Pipeline

Cancer and viral infection treatment information.

Pet2DAO

Building the next generation DAO

Most recent news and events

Oncotelic Happenings

Dr. Vuong Trieu presented at the BIO International Convention 2023, Boston, MA (June 5-8, 2023) Learn more >

Dr. Vuong Trieu presented at the 12th AACR-JCA Joint Conference: Breakthroughs in Cancer Research— Translating Knowledge into Practice (December 10 – 14, 2022, Maui, Hawaii) Learn more >

Dr. Cynthia Lee etc. presented at the SNO 2022 conference (November 16-20, 2022 | Tampa bay, FL)

Learn more 1>

Learn more 2>

Dr. Anthony Maida presented at the SITC 2022 conference (November 8-12, 2022 | Boston, MA) Learn more >

Dr. Vuong Trieu presented at the 7th JCA-AACR Special Joint Conference (July 8-10, 2022) Learn more >

Dr. Vuong Trieu presented at the BIO International Convention, San Diego (June 13-16, 2022) Learn more >

AACR Annual Meeting 2022. April 8 – 13, 2022, New Orleans, Louisiana. Learn more >

Dr. Vuong Trieu presented at the MedInvest Pharmaceutical & Biotechnology Investor Conference (March 30-31, 2022) Learn more >

Biotechgate Digital Partnering February 2022 (7 – 11 Feb, 2022) Learn more >

2nd Annual TGF-β for Immuno-Oncology Drug Development Summit (tgf-beta-summit.com) (January 25, 2022 to January 27, 2022) Learn more >

Oncotelic Therapeutics Investor Presentation 10-26-2021. Learn more >

11 Billion $

target markets

100 Plus

patent applications

2 Key

clinical programs

30 Years

experience

Questions or Comments?

Copyright © 2020 Oncotelic Inc., a TGF ImmunoOncology Company. All rights reserved.